These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20182415)

  • 1. Recent changes in vancomycin use in renal failure.
    Vandecasteele SJ; De Vriese AS
    Kidney Int; 2010 May; 77(9):760-4. PubMed ID: 20182415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
    Wong-Beringer A; Joo J; Tse E; Beringer P
    Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin and nephrotoxicity: just another myth?
    Davies SW; Guidry CA; Petroze RT; Hranjec T; Sawyer RG
    J Trauma Acute Care Surg; 2013 Nov; 75(5):830-5. PubMed ID: 24158202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin nephrotoxicity: myths and facts.
    Gupta A; Biyani M; Khaira A
    Neth J Med; 2011 Sep; 69(9):379-83. PubMed ID: 21978980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of vancomycin-induced nephrotoxicity in the population with chronic kidney disease.
    Panwar B; Johnson VA; Patel M; Balkovetz DF
    Am J Med Sci; 2013 May; 345(5):396-9. PubMed ID: 23103440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin: a 50-something-year-old antibiotic we still don't understand.
    Schilling A; Neuner E; Rehm SJ
    Cleve Clin J Med; 2011 Jul; 78(7):465-71. PubMed ID: 21724929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of continuous-infusion vancomycin.
    DiMondi VP; Rafferty K
    Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties.
    Vandecasteele SJ; De Vriese AS; Tacconelli E
    J Antimicrob Chemother; 2013 Apr; 68(4):743-8. PubMed ID: 23249839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ; De Bacquer D; De Vriese AS
    Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin therapy for serious staphylococcal infections in chronic hemodialysis patients.
    Bierman MH; Needham-Walker CA; Hammeke M; Egan JD
    J Dial; 1980; 4(4):179-84. PubMed ID: 7204716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the 'creeps'?
    Brink AJ
    Curr Opin Crit Care; 2012 Oct; 18(5):451-9. PubMed ID: 22941206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in dosing vancomycin.
    Koppula S; Ruben S; Bangash F; Szerlip HM
    Am J Med Sci; 2015 Feb; 349(2):137-9. PubMed ID: 25437128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.